Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Challenging cytomegalovirus data in glioblastoma.

Literature DB >> 24353326

Challenging cytomegalovirus data in glioblastoma.

Wolfgang Wick¹, Antje Wick, Michael Platten.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 24353326 PMCID： PMC3870834 DOI： 10.1093/neuonc/not212

Source DB: PubMed Journal: Neuro Oncol ISSN： 1522-8517 Impact factor: 12.300

× No keyword cloud information.

4 in total

1. Survival in patients with glioblastoma receiving valganciclovir.

Authors: Cecilia Söderberg-Nauclér; Afsar Rahbar; Giuseppe Stragliotto
Journal: N Engl J Med Date: 2013-09-05 Impact factor: 91.245

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors: Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal: N Engl J Med Date: 2005-03-10 Impact factor: 91.245

3. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.

Authors: Giuseppe Stragliotto; Afsar Rahbar; Nina Wolmer Solberg; Anders Lilja; Chato Taher; Abiel Orrego; Birgitta Bjurman; Charlotte Tammik; Petra Skarman; Inti Peredo; Cecilia Söderberg-Nauclér
Journal: Int J Cancer Date: 2013-03-13 Impact factor: 7.396

Review 4. Molecular neuro-oncology in clinical practice: a new horizon.

Authors: Michael Weller; Stefan M Pfister; Wolfgang Wick; Monika E Hegi; Guido Reifenberger; Roger Stupp
Journal: Lancet Oncol Date: 2013-08 Impact factor: 41.316

4 in total

5 in total

Challenging cytomegalovirus data in glioblastoma.

1. Survival in patients with glioblastoma receiving valganciclovir.

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

3. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.

Review 4. Molecular neuro-oncology in clinical practice: a new horizon.

1. CMV infection and glioma, a highly controversial concept struggling in the clinical arena.

2. Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.

Review 3. Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options.

4. The future of high-grade glioma: Where we are and where are we going.

Review 5. Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies.